Jiangsu Sihuan Bioengineering Co., Ltd
CN¥3.08-CN¥0.11 (-3.45%)
Jiangsu Sihuan Bioengineering Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
SHH · 600200.SS · CNY
Stock price, dividends, earnings
Quote as of Dec 29, 2025, 08:49 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
JiangSu WuZhong Pharmaceutical Development Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 97.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
JiangSu WuZhong Pharmaceutical Development Co., Ltd.’s forward annual dividend is CN¥0.06 per share, paid annual. The forward yield is 19.31% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow JiangSu WuZhong Pharmaceutical Development Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
JiangSu WuZhong Pharmaceutical Development Co., Ltd., along with its affiliated entities, operates as a diversified Chinese enterprise with interests spanning the pharmaceutical, real estate, and chemical industries. The company is actively involved in the research, production, and sale of a broad spectrum of pharmaceutical products. These include medications targeting infections, digestive ailments, cardiovascular and cerebrovascular conditions, viral diseases, vitamin deficiencies, and hemostasis. Its pharmaceutical offerings also encompass immunomodulators, featuring biopharmaceuticals, traditional chemical drugs, and contemporary Chinese medicines. These treatments are available in diverse formats, such as intravenous solutions, injectable powders and liquids, capsules, granular forms, tablets, emulsions, and oral liquid preparations. In its chemical division, the company focuses on the development, manufacturing, and distribution of various dyes and their intermediates. Additionally, its real estate arm undertakes the construction of both market-rate and subsidized residential properties. Founded in 1994, the company is based in Suzhou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:30 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥3.08-CN¥0.11 (-3.45%)
Jiangsu Sihuan Bioengineering Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
CN¥7.70-CN¥0.16 (-2.04%)
Jiangsu Nanfang Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.89% below the high.
CN¥11.00-CN¥0.80 (-6.78%)
Shandong Sito Bio-technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.39% below the high.
CN¥5.19-CN¥0.15 (-2.81%)
Hainan Huluwa Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.95% below the high.
CN¥5.34-CN¥0.13 (-2.38%)
Tiansheng Pharmaceutical Group Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 14.97% below the high.
CN¥11.85-CN¥0.56 (-4.51%)
Jiangsu gdk Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 62.02% below the high.
CN¥6.94-CN¥0.22 (-3.07%)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.25% below the high.
CN¥0.51+CN¥0.05 (+10.87%)
Shenzhen GuoHua Network Security Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 96.35% below the high.